These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 9147435)
21. Editorial comment: boosted PIs and metabolism--it's not just the ritonavir. Moyle GJ AIDS Read; 2005 Oct; 15(10):531. PubMed ID: 16265769 [No Abstract] [Full Text] [Related]
22. Lopinavir/ritonavir monotherapy as a simplification strategy in routine clinical practice. Moltó J; Santos JR; Negredo E; Miranda C; Videla S; Clotet B J Antimicrob Chemother; 2007 Aug; 60(2):436-9. PubMed ID: 17556354 [TBL] [Abstract][Full Text] [Related]
23. Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment. Seminari E; De Bona A; Gentilini G; Galli L; Schira G; Gianotti N; Uberti-Foppa C; Soldarini A; Dorigatti F; Lazzarin A; Castagna A J Antimicrob Chemother; 2007 Oct; 60(4):831-6. PubMed ID: 17684056 [TBL] [Abstract][Full Text] [Related]
24. [Efficacy of ritonavir in HIV positive patients pretreated with nucleoside analogues]. Gómez-Cano M; Soriano V; Polo R; Valencia E; Adrados M; González-Lahoz J An Med Interna; 1998 Feb; 15(2):83-6. PubMed ID: 9542203 [TBL] [Abstract][Full Text] [Related]
25. Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients. Delfraissy JF; Flandre P; Delaugerre C; Ghosn J; Horban A; Girard PM; Norton M; Rouzioux C; Taburet AM; Cohen-Codar I; Van PN; Chauvin JP AIDS; 2008 Jan; 22(3):385-93. PubMed ID: 18195565 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and tolerability of once- versus twice-daily lopinavir/ritonavir treatment in HIV-1-infected children. la Porte C; van Heeswijk R; Mitchell CD; Zhang G; Parker J; Rongkavilit C Antivir Ther; 2009; 14(4):603-6. PubMed ID: 19578247 [TBL] [Abstract][Full Text] [Related]
27. The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients. Chetchotisakd P Expert Rev Anti Infect Ther; 2009 Sep; 7(7):801-5. PubMed ID: 19735222 [TBL] [Abstract][Full Text] [Related]
28. Improved tolerability and quality of life with the new lopinavir/ritonavir tablet formulation. Olmo M; Ferrer E; Curto J; Barragán P; Saumoy M; Perulero N; Podzamczer D J Infect; 2008 Dec; 57(6):503-5. PubMed ID: 18952298 [No Abstract] [Full Text] [Related]
29. Cholesterol levels in HIV-HCV infected patients treated with lopinavir/r: results from the SCOLTA project. De Socio GV; Bonfanti P; Ricci E; Orofino G; Madeddu G; Penco G; Gianelli E; Martinelli C; Carradori S; Quirino T; Rizzardini G; Biomed Pharmacother; 2008 Jan; 62(1):16-20. PubMed ID: 17851026 [TBL] [Abstract][Full Text] [Related]
30. Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors. Pollmann H; Richter H; Jürgens H Thromb Haemost; 1998 Jun; 79(6):1213-4. PubMed ID: 9657450 [No Abstract] [Full Text] [Related]
31. Ritonavir and indinavir one year later. TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094 [No Abstract] [Full Text] [Related]
33. HIV protease inhibitors and increased bleeding in hemophilia? Hélal A CMAJ; 1997 Jan; 156(1):90, 94-5. PubMed ID: 9006575 [No Abstract] [Full Text] [Related]
34. A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients. Ananworanich J; Hill A; Siangphoe U; Ruxrungtham K; Prasithsirikul W; Chetchotisakd P; Kiertiburanakul S; Munsakul W; Raksakulkarn P; Tansuphasawadikul S; Nuesch R; Cooper DA; Hirschel B; Antivir Ther; 2005; 10(6):761-7. PubMed ID: 16218176 [TBL] [Abstract][Full Text] [Related]
35. Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy. Badía X; Podzamczer D; Moral I; Roset M; Arnaiz JA; Loncà M; Casiró A; Rosón B; Gatell JM; Antivir Ther; 2004 Dec; 9(6):979-85. PubMed ID: 15651756 [TBL] [Abstract][Full Text] [Related]
36. Spinal epidural lipomatosis in a human immunodeficiency virus-positive patient receiving steroids and protease inhibitor therapy. Ebright JR; Stellini MA; Tselis AC Clin Infect Dis; 2001 Mar; 32(5):E90-1. PubMed ID: 11229864 [TBL] [Abstract][Full Text] [Related]
37. Uveitis associated with concurrent administration of rifabutin and lopinavir/ritonavir (Kaletra). Lin HC; Lu PL; Chang CH Eye (Lond); 2007 Dec; 21(12):1540-1. PubMed ID: 17962822 [No Abstract] [Full Text] [Related]
38. The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1,250 mg twice-daily regimen in HIV-infected patients. Justesen US; Hansen IM; Andersen AB; Klitgaard NA; Black FT; Gerstoft J; Mathiesen LR; Pedersen C HIV Med; 2005 Sep; 6(5):334-40. PubMed ID: 16156881 [TBL] [Abstract][Full Text] [Related]